What independence actually buys you

Advice that costs us money to give

We are privately held, own no platform, and earn nothing on what you buy from anyone else.

A recent engagement

The proposal we made smaller

A clinical-stage client asked us to price a safety function for two INDs. Our first proposal included a validated hosted safety database.

The client asked whether it could be run manually instead. It could, and we said so. For their case volumes and stage, a disciplined manual process meets the FDA's requirements. So we withdrew the platform from our own proposal.

We then documented what a manual system does not give you and listed specific triggers for recommending a platform later.

What that shows

We priced against our own interest

The recommendation reduced our own fee because it was right for that stage.

The downside was written down

Limitations appeared in the proposal itself before signing.

The exit was designed in

Records were structured for a later move without re-entry.

The review is scheduled

Change-course triggers are formally assessed in governance reviews.

A firm with a product to place cannot give you this answer. That structural position is what you are hiring.

The structural position

What we are not

01

Not a CRO

We help select and qualify CROs without competing for the contract.

02

Not a CDMO or lab

We audit partners on your behalf; we do not manufacture, test, or receive anything for an introduction.

03

Not a notified body

We prepare documentation but have no role in certifying you.

04

Not a software vendor

We can recommend, validate, or decline a platform without reselling one.

See the service lines